Insider · CIK 0002148701
Susan Abu-Absi
Files at AURA (Aura Biosciences, Inc.). First filing -, latest -.
In brief
Susan Abu-Absi files SEC Form 4 as COO at AURA (Aura Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Susan Abu-Absi has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | AURA Aura Biosciences, Inc. | AGrant or award Common Stock | +134,513 | $0.00 | $0 | 134,513 | 42 d ago |
| Sep 1, 2026 | AURA Aura Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +265,487 | $0.00 | $0 | 265,487 | 42 d ago |
Questions about Susan Abu-Absi
Answered from the filings on this page, as of the latest one.
Is Susan Abu-Absi buying or selling?
Susan Abu-Absi has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Susan Abu-Absi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Susan Abu-Absi has 0.
Where does Susan Abu-Absi file Form 4?
Susan Abu-Absi has filed Form 4 at AURA (Aura Biosciences, Inc.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.